A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults
Conditions
Interventions
- BIOLOGICAL: 7.5μg /0.5ml
- BIOLOGICAL: 15.0μg /0.5ml
- BIOLOGICAL: 30.0μg /0.5ml
- BIOLOGICAL: 0/0.5ml placebo
Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Collaborators